Donate Now
  • What We've Learned
Developing a Patient Survey to Measure Quality of Care for Rheumatoid Arthritis
blue-and-silver-stetoscope-40568-scaled
Scientific Study Title:
Development of a Patient-Centered Rheumatoid Arthritis Quality of Care Survey
Start Date:
  • 2020
End Date:
  • 2022
Research Category
Tags

Why did we do this research?

Monitoring the quality of care people with Rheumatoid Arthritis receive is important yet challenging. To address this challenge, we created the Rheumatoid Arthritis Quality of Care Survey (RAQCS). The goal of this survey was to have a standardized way to measure the quality of care based on a set of quality measures. The measures used are outlined in a national quality improvement framework for rheumatoid arthritis. This study aimed to create and test a tool that could help health care providers understand how well they are meeting their patients’ needs according to these measures.

What did we do?

The creation of the Rheumatoid Arthritis Quality of Care Survey involved three steps:

  • A team of health care providers, researchers, and rheumatoid arthritis patients developed a survey. The survey was based on 21 quality measures, that covered important aspects of rheumatoid arthritis care, such as providing counselling for smoking cessation, exercise, and lifestyle habits.
  • To ensure the questions were clear and appropriate, interviews were held with rheumatoid arthritis patients. Based on their feedback, the survey was revised.
  • The survey was given to a group of rheumatoid arthritis patients who were part of a long-term study group called Rheum4U. The responses from the survey were compared with information from the patients' medical records to see how well the survey's findings matched real-world data.

What did we find?

  • 53 people completed the Rheumatoid Arthritis Quality of Care Survey.
  • For 13 out of 20 quality measures, the survey showed that 70% or more of the care provided met the expected standards.
  • There were areas identified where care could be improved, such as:
  • in recording patients' body mass index (BMI),
  • smoking status,
  • discussing physical activity,
  • managing other health conditions alongside rheumatoid arthritis, and
  • assessing the severity of patients' rheumatoid arthritis symptoms.
  • When comparing the survey results with the medical records, there was a high level of agreement for nine out of the 20 measures.

The Research Team

Principal Investigator

  • Claire Barber, MD, PhD, FRCPC; Research Scientist, Arthritis Research Canada (University of Calgary)

Co-investigators

  • Cheryl Barnabe, MD, MSc, FRCPC; Research Scientist, Arthritis Research Canada (University of Calgary)
  • Glen Hazlewood, MD, PhD, FRCPC; Research Scientist, Arthritis Research Canada (University of Calgary)
  • Joanne Homik, MD, MSc, FRCPC
  • Diane Lacaille, MD, MHSc, FRCPC; Scientific Director, Arthritis Research Canada (University of British Columbia)
  • Linda Li, BSc PT, MSc, PhD, FCAHS; Senior Research Scientist, Arthritis Research Canada (University of British Columbia)
  • Paul MacMullan, MD, MB BCh
  • Deborah Marshall, PhD; Senior Research Scientist, Arthritis Research Canada (University of Calgary)
  • Dianne Mosher, MD
  • James Rankin, PhD, ACNP
  • Karen Then, PhD, ACNP
  • Karen Tsui, Arthritis Research Canada, Arthritis Patient Advisory Board
  • Kelly English , Arthritis Research Canada, Arthritis Patient Advisory Board

Additional Study Team Members

  • Sarah Sloss

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More